- Home
- INGR vs BBIO Comparison
INGR vs BBIO Comparison
Compare INGR & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGR
- BBIO
- Stock Information
- Founded
- INGR 1906
- BBIO 2015
- Country
- INGR United States
- BBIO United States
- Employees
- INGR N/A
- BBIO N/A
- Industry
- INGR Packaged Foods
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- INGR Consumer Staples
- BBIO Health Care
- Exchange
- INGR Nasdaq
- BBIO Nasdaq
- Market Cap
- INGR 8.0B
- BBIO 9.4B
- IPO Year
- INGR 1997
- BBIO 2019
- Fundamental
- Price
- INGR $120.97
- BBIO $55.32
- Analyst Decision
- INGR Hold
- BBIO Strong Buy
- Analyst Count
- INGR 6
- BBIO 16
- Target Price
- INGR $147.83
- BBIO $64.44
- AVG Volume (30 Days)
- INGR 622.8K
- BBIO 2.0M
- Earning Date
- INGR 11-04-2025
- BBIO 11-11-2025
- Dividend Yield
- INGR 2.63%
- BBIO N/A
- EPS Growth
- INGR 4.50
- BBIO N/A
- EPS
- INGR 10.23
- BBIO N/A
- Revenue
- INGR $7,316,000,000.00
- BBIO $235,812,000.00
- Revenue This Year
- INGR $1.99
- BBIO $115.46
- Revenue Next Year
- INGR $2.60
- BBIO $65.03
- P/E Ratio
- INGR $11.90
- BBIO N/A
- Revenue Growth
- INGR N/A
- BBIO 7.62
- 52 Week Low
- INGR $119.31
- BBIO $21.72
- 52 Week High
- INGR $155.44
- BBIO $55.32
- Technical
- Relative Strength Index (RSI)
- INGR 36.13
- BBIO 59.91
- Support Level
- INGR $119.41
- BBIO $52.97
- Resistance Level
- INGR $121.22
- BBIO $55.13
- Average True Range (ATR)
- INGR 1.71
- BBIO 1.58
- MACD
- INGR 0.02
- BBIO 0.16
- Stochastic Oscillator
- INGR 23.59
- BBIO 84.41
About INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.